High-affinity binding to the GM-CSF receptor requires intact N- glycosylation sites in the extracellular domain of the β subunit

Blood

Volumn 95, Issue 11, 2000, Pages 3357-3362

  Niu, Linghao ^a   Heaney, Mark L ^a   Vera, Juan Carlos ^a   Golde, David W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ASPARAGINE; ASPARTIC ACID; GLYCOPROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; BETA CHAIN; CELL FRACTIONATION; CELL STRAIN COS1; GLYCOSYLATION; IMMUNOFLUORESCENCE; LIGAND BINDING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 0034210621     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.11.3357     Document Type: Article

References (48)

1. Gasson JC. Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood. 1991;77:1131.
2. Griffin JD, Cannistra SA, Sullivan R, Demetri GD, Ernst TJ, Kanakura Y. The biology of GM-CSF: regulation of production and interaction with its receptor. Int J Cell Cloning. 1990;8:35.
3. Gearing DP, King JA, Gough NM, Nicola NA. Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor. EMBO J. 1989;8:3667.
4. Baldwin GC, Golde DW, Widhopf GF, Economou J, Gasson JC. Identification and characterization of a low-affinity granulocyte-macrophage colony-stimulating factor receptor on primary and cultured human melanoma cells. Blood. 1991;78: 609.
5. Chiba S, Shibuya K, Piao YF, et al. Identification and cellular distribution of distinct proteins forming human GM-CSF receptor. Cell Regulation. 1990;1:327.
6. Metcalf D, Nicola NA, Gearing DP, Gough NM. Low-affinity placenta-derived receptors for human granulocyte-macrophage colony-stimulating factor can deliver a proliferative signal to murine hemopoietic cells. Proc Natl Acad of Sci U S A. 1990;87:4670.
7. Kitamura T, Sato N, Arai K, Miyajima A. Expression cloning of the human IL-3 receptor cDNA reveals a shared beta subunit for the human IL-3 and GM-CSF receptors. Cell. 1991;66:1165.
8. Hayashida K, Kitamura T, Gorman DM, Arai K, Yokota T, Miyajima A. Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): reconstitution of a high-affinity GM-CSF receptor. Proc Natl Acad Sci U S A. 1990;87:9655.
9. Park LS, Martin U, Sorensen R, et al. Cloning of the low-affinity murine granulocyte-macrophage colony-stimulating factor receptor and reconstitution of a high-affinity receptor complex. Proc Natl Acad Sci U S A. 1992;89:4295.
10. Bazan JF. Structural design and molecular evolution of a cylokine receptor superfamily. Proc Natl Acad Sci U S A. 1990;87:6934.
11. Gasson JC, Kaufman SE, Weisbart RH, Tomonaga M, Golde DW. High-affinity binding of granulocyte-macrophage colony-stimulating factor to normal and leukemic human myeloid cells. Proc Natl Acad Sci U S A. 1986;83:669.
12. Chiba S, Tojo A, Kitamura T, Urabe A, Miyazono K, Takaku F. Characterization and molecular features of the cell surface receptor for human granulocyte-macrophage colony-stimulating factor. Leukemia. 1990;4:29.
13. Cannistra SA, Koenigsmann M, DiCarlo J, Groshek P, Griffin JD. Differentiation-associated expression of two functionally distinct classes of granulocyte-macrophage colony-stimulating factor receptors by human myeloid cells. J Biol Chem. 1990;265:12,656.
14. Park LS, Friend D, Gillis S, Urdal DL. Characterization of the cell surface receptor for human granulocyte/macrophage colony-stimulating factor. J Exp Med. 1986;164:251.
15. Chiba S, Shibuya K, Miyazono K, et al. Affinity purification of human granulocyte macrophage colony-stimulating factor receptor alpha-chain. Demonstration of binding by photoaffinity labeling. J Biol Chem. 1990;265:19,777.
16. Bussolino F, Wang JM, Defilippi P, et al. Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature. 1989;337:471.
17. Baldwin GC, Benveniste EN, Chung GY, Gasson JC, Golde DW. Identification and characterization of a high-affinity granulocyte-macrophage colony-stimulating factor receptor on primary rat oligodendrocytes. Blood. 1993;82:3279.
18. Ding DX, Vera JC, Heaney ML, Golde DW. N-Glycosylation of the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit is essential for ligand binding and signal transduction. J Biol Chem. 1995;270:24,580.
19. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977;74:5463.
20. McCutchan JH, Pagano JS. Enchancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethylaminoethyl-dextran. J Natl Cancer Inst. 1968;41:351.
21. DiPersio JF, Hedvat C, Ford CF, Golde DW, Gasson JC. Characterization of the soluble human granulocyte-macrophage colony-stimulating factor receptor complex. J Biol Chem. 1991;266:279.
22. Shibuya K, Chiba S, Miyagawa K, Kitamura T, Miyazono K, Takaku F. Structural and functional analyses of glycosylation on the distinct molecules of human GM-CSF receptors. Eur J Biochem. 1991;198:659.
23. Kornfeld R, Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem. 1985;54:631.
24. West CM. Current ideas on the significance of protein glycosylation. Mol Cell Biochem. 1986; 72:3.
25. Chochola J, Fahre C, Bellan C, et al. Structural and functional analysis of the human vasoactive intestinal peptide receptor glycosylation. Alteration of receptor function by wheat germ agglutinin. J Biol Chem. 1993;268:2312.
26. Feige JJ, Baird A. Glycosylation of the basic fibroblast growth factor receptor. The contribution of carbohydrate to receptor function. J Biol Chem. 1988;263:14,023.
27. Russo D, Chazenbalk GD, Nagayama Y, Wadsworth HL, Rapoport B. Site-directed mutagenesis of the human thyrotropin receptor role of asparagine-linked oligosaccharides in the expression of a functional receptor. Mol Endocrinol. 1991;5:29.
28. Semmes OJ, Sztein MS, Bailey JM, Merritt WD. Tunicamycin inhibits function and expression of the high-affinity IL-2 receptor in a murine IL-2-dependent cell line. Int J Immunopharmacol. 1992;14:583.
29. Szecowka J, Tai LR, Goodman HM. Effects of tunicamycin on growth hormone binding in rat adipocytes. Endocrinology. 1990;126:1834.
30. Kaushal S, Ridge KD, Khorana HG. Structure and function in rhodopsin: the role of asparagine-linked glycosylation. Proc Natl Acad Sci U S A. 1994;91:4024.
31. Leconte I, Auzan C, Debant A, Rossi B, Clauser E. N-Linked oligosaccharide chains of the insulin receptor beta subunit are essential for transmembrane signaling. J Biol Chem. 1992;267:17,415.
32. Leconte I, Carpentier JL, Clauser E. The functions of the human insulin receptor are affected in different ways by mutation of each of the tour N-glycosylation sites in the beta subunit. J Biol Chem. 1994;269:18,062.
33. Moller LB, Pollanen J, Ronne E, Pedersen N, Blasi F. N-Linked glycosylation of the ligand-binding domain of the human urokinase receptor contributes to the affinity for its ligand. J Biol Chem. 1993;268:11,152.
34. Feizi T, Childs RA. Carbohydrates as antigenic determinants of glycoproteins. Biochem J. 1987; 245:1.
35. Schauer R. Sialic acids as antigenic determinants of complex carbohydrates. Adv Exp Med Biol. 1988;228:47.
36. Ashwell G, Harford J. Carbohydrate-specific receptors of the liver. Annu Rev Biochem. 1982;51: 531.
37. McFarlane IG. Hepatic clearance of serum glycoproteins. Clin Sci. 1983;64:127.
38. Baenziger JU. The role of glycosylation in protein recognition. Warner-Lambert Parke-Davis Award lecture. Am J Pathol. 1985;121:382.
39. Hotchkiss A, Refino CJ, Leonard CK, et al. The influence of carbohydrate structure on the clearance of recombinant tissue-type plasminogen activator. Thromb Haemost. 1988;60:255.
40. Fukuda MN, Sasaki H, Lopez L, Fukuda M. Survival of recombinant erythropoietin in the circulation: the role of carbohydrates. Blood. 1989; 73:84.
41. Asano T, Takata K, Katagiri H, et al. The role of N-glycosylation in the targeting and stability of GLUT1 glucose transporter. FEBS Lett. 1993; 324:258.
42. Bastian W, Zhu J, Way B, Lockwood D, Livingston J. Glycosylation of Asn397 or Asn418 is required for normal insulin receptor biosynthesis and processing. Diabetes. 1993;42:966.
43. Collier E, Carpentier JL, Beitz L, Carol H, Taylor SI, Gorden P. Specific glycosylation site mutations of the insulin receptor alpha subunit impair intracellular transport. Biochemistry. 1993;32:7818.
44. Tifft CJ, Proia RL, Camerini-Otero RD. The folding and cell surface expression of CD4 requires glycosylation. J Biol Chem. 1992;267:3268.
45. Niu L, Golde DW, Vera JC, Heaney ML. Kinetic resolution of two mechanisms for high-affinity granulocyte-macrophage colony-stimulating factor binding to its receptor. Blood. 1999;94:3748.
46. Davis DP, Rozell TG, Liu X, Segaloff DL. The six N-linked carbohydrates of the lutropin/choriogonadotropin receptor are not absolutely required for correct folding, cell surface expression, hormone binding, or signal transduction. Mol Endocrinol. 1997;11:550.
47. Diederichs K, Boone T, Karplus PA. Novel fold and putative receptor binding site of granulocyte-macrophage colony-stimulating factor. Science. 1991;254:1779.
48. Kaushansky K, O'Hara PJ, Hart CE, Forstrom JW, Hagen FS. Role of carbohydrate in the function of human granulocyte-macrophage colony-stimulating factor. Biochemistry. 1987;26:4861.